Ionis Pharmaceuticals Inc. Common Stock vs Prudential Financial Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Prudential Financial Inc trades at $114.42 (market cap $39.13B). The key difference: Prudential Financial Inc is far larger — about 5.6× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Prudential Financial Inc pays a 4.94% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Prudential Financial Inc for 146 Days on average.
| IONS | PRU | |
|---|---|---|
Market Cap | $7.04B | $39.13B |
Volume | 2,977,440 | 1,369,167 |
Sector | Health | Financials |
52-Week High | $86.50 | $125.13 |
52-Week Low | $42.38 | $92.00 |
Typical Hold Time | 0 Days | 146 Days |
Enterprise Value | $6.60B | $67.90B |
Dividend Yield | — | 4.94% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Prudential Financial (PRU) trades at $113.49, showing minimal daily movement (+0.09%). The stock presents mixed signals with bearish technical indicators but fundamentally attractive valuation metrics including a P/E of 10.28 and P/S of 0.61. Recent earnings show two consecutive quarterly beats, while the company executes strategic initiatives including a $185 million Alexforbes stake sale and rebranding to Prudential Wealth Advisors.
PRU offers value investment appeal with strong profitability metrics (12.46% ROE) and dividend income potential, though facing headwinds from bearish technical trends and mixed analyst sentiment. The company's strategic focus on core businesses and cost reduction provides upside potential, while interest rate sensitivity and competitive pressures remain key monitoring points for investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →